We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Intravenous Fluids as a Route of Microplastic and Plasticizer Exposure in U.S. Patients: A Preliminary Assessment.
No summary available — this paper's abstract is not included in the open metadata provided by the publisher. Learn why →
More Papers Like This
Microplastic Particles and Infusion Therapy — Evidence, Implications, and Unanswered Questions
AI summary Read the abstract
Researchers reviewed evidence that medical infusion devices and pharmaceutical containers release microscopic plastic particles directly into patients' bloodstreams, identifying a significant but underexamined exposure route and calling for updated industry standards and interdisciplinary research to assess clinical risks.
Microplastic Particles and Infusion Therapy — Evidence, Implications, and Unanswered Questions
AI summary Read the abstract
Researchers highlighted microplastic exposure via medical infusion devices and pharmaceutical containers as an underappreciated but significant route of human exposure, reviewing current evidence on particle-body interactions and identifying gaps between emerging clinical research and existing industry testing standards and regulations.
Plastic particles in medicine: A systematic review of exposure and effects to human health
AI summary Read the abstract
Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
AI summary Read the abstract
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Microplastics in neonates: an overlooked cost of parenteral nutrition
AI summary Read the abstract
Researchers detected microplastics in neonatal blood at levels that increased with parenteral nutrition duration, with larger particles over 60 µm found exclusively in long-term recipients — suggesting that intravenous nutrition delivery systems may be an underrecognized iatrogenic source of microplastic exposure in vulnerable newborns.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.